[{"address1": "333 Las Olas Way", "address2": "CU4 Suite 433", "city": "Fort Lauderdale", "state": "FL", "zip": "33301", "country": "United States", "phone": "954-515-0810", "website": "https://sunshinebiopharma.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine Biopharma, Inc. is based in Fort Lauderdale, Florida.", "fullTimeEmployees": 44, "companyOfficers": [{"maxAge": 1, "name": "Dr. Steve N. Slilaty Ph.D.", "age": 72, "title": "Chairman, President & CEO", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 640000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Camille  Sebaaly", "age": 65, "title": "CFO & Secretary", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 695000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Abderrazzak  Merzouki", "age": 60, "title": "COO & Director", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 340000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Malek  Chamoun", "age": 39, "title": "Chief Development Officer", "yearBorn": 1985, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michel  Roy", "title": "Chief Commercial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert G. Ferreira", "age": 62, "title": "President of Sunshine Bio Investments Inc", "yearBorn": 1962, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.31, "open": 2.31, "dayLow": 2.31, "dayHigh": 2.4868, "regularMarketPreviousClose": 2.31, "regularMarketOpen": 2.31, "regularMarketDayLow": 2.31, "regularMarketDayHigh": 2.4868, "payoutRatio": 0.0, "beta": -1.477, "forwardPE": 0.011961962, "volume": 38426, "regularMarketVolume": 38426, "averageVolume": 101989, "averageVolume10days": 42840, "averageDailyVolume10Day": 42840, "bid": 1.78, "ask": 3.05, "bidSize": 2, "askSize": 2, "marketCap": 6472933, "fiftyTwoWeekLow": 2.022, "fiftyTwoWeekHigh": 266.0, "priceToSalesTrailing12Months": 0.19639055, "fiftyDayAverage": 2.71764, "twoHundredDayAverage": 4.399615, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -6857916, "profitMargins": -0.12821999, "floatShares": 1997620, "sharesOutstanding": 2708340, "sharesShort": 57523, "sharesShortPriorMonth": 78227, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.0212, "heldPercentInsiders": 0.07215, "heldPercentInstitutions": 0.01123, "shortRatio": 1.03, "shortPercentOfFloat": 0.021300001, "impliedSharesOutstanding": 2708340, "bookValue": 12.515, "priceToBook": 0.19097084, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -4225928, "trailingEps": -127.9, "forwardEps": 199.8, "lastSplitFactor": "1:20", "lastSplitDate": 1723075200, "enterpriseToRevenue": -0.208, "enterpriseToEbitda": 1.44, "52WeekChange": -0.9798276, "SandP52WeekChange": 0.121255875, "quoteType": "EQUITY", "currentPrice": 2.39, "targetHighPrice": 300.0, "targetLowPrice": 300.0, "targetMeanPrice": 300.0, "targetMedianPrice": 300.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 12206655, "totalCashPerShare": 6.104, "ebitda": -4761139, "totalDebt": 556551, "quickRatio": 3.406, "currentRatio": 5.737, "totalRevenue": 32959492, "debtToEquity": 2.223, "revenuePerShare": 197.42, "returnOnAssets": -0.10747, "returnOnEquity": -0.17982, "grossProfits": 10144791, "freeCashflow": -12837234, "operatingCashflow": -11813574, "revenueGrowth": 0.416, "grossMargins": 0.3078, "ebitdaMargins": -0.14445, "operatingMargins": -0.13116, "financialCurrency": "USD", "symbol": "SBFM", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 3.4632106, "regularMarketPrice": 2.39, "corporateActions": [], "postMarketTime": 1741390961, "regularMarketTime": 1741381200, "exchange": "NCM", "messageBoardId": "finmb_78729055", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "longName": "Sunshine Biopharma, Inc.", "marketState": "CLOSED", "shortName": "Sunshine Biopharma Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1644935400000, "postMarketChangePercent": 0.104595, "postMarketPrice": 2.3925, "postMarketChange": 0.00249982, "regularMarketChange": 0.08000016, "regularMarketDayRange": "2.31 - 2.4868", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 101989, "fiftyTwoWeekLowChange": 0.36800003, "fiftyTwoWeekLowChangePercent": 0.18199803, "fiftyTwoWeekRange": "2.022 - 266.0", "fiftyTwoWeekHighChange": -263.61, "fiftyTwoWeekHighChangePercent": -0.99101496, "fiftyTwoWeekChangePercent": -97.98276, "dividendDate": 1586131200, "earningsTimestampStart": 1743019200, "earningsTimestampEnd": 1743451200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -127.9, "epsForward": 199.8, "fiftyDayAverageChange": -0.32763982, "fiftyDayAverageChangePercent": -0.12056042, "twoHundredDayAverageChange": -2.0096147, "twoHundredDayAverageChangePercent": -0.4567706, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2022-02-15", "cryptoTradeable": false, "displayName": "Sunshine Biopharma", "trailingPegRatio": null, "__fetch_time": "2025-03-08"}]